September 9, 2016

2016 14th Annual District Council 16 Golf Invitational witnessed a huge turnout of over 140 golfers, who came together to support the cause while generating approximately $105k for mesothelioma research!

read more...


August 25, 2016

2016 Aim to Cure event hosted by Foundation Board Member and Retired International Pipetrades Representative Jim Kellogg. This event saw another great turnout of over 100 supporters. It netted over $51,000 for mesothelioma research, 100% of which will be used in the research and development of new mesothelioma treatment options!

read more...


June 2016
2016 Roger Hamilton Memorial Golf Invitational a great event that witnessed a large turnout and generated approximately $60,000 for mesothelioma research!

read more...


December 2015
District Council 16 gives $230K for Mesothelioma Cancer Treatment Trials at USC Norris, Los Angeles.
October 2015
DC 16 Aim to Cure event supports Dr. Gill and safer EPH-B4 cancer treatment.

Southern California Pipetrades District Council 16 organized its annual Aim to Cure event which attracted 90 shooters and generated $40,000 for mesothelioma research! Dr. Parkash Gill presented how cancer treatments like EPh-B4 target cancerous cells while leaving healthy tissue unharmed.

read more...


September 2015
Dr. Gill, EPH-B4 and Cell Blocker

Presently our sEphB4-HSA drug is being tested within an extended Phase I clinical trial on patients with mesothelioma cancer.

read more...


Bring your Mesothelioma questions to us: click HERE

DONATIONS for cancer cure

100 percent of all proceeds received are going to the USC Norris Comprehensive Cancer Medical Center in Los Angeles to support the FDA clinical trials. These trials include Veglin, a mesothelioma cancer treatment. Veglin manipulates the blood vessels to starve a malignant tumor while alleviating fluid build up in the lungs

Support the hope in this research and click HERE


Patient Assistance Programs are offered by many pharmaceutical manufacturers to help pay for medications. These offers are sometimes called Indigent Drug Programs. Use our link just following, and learn whether a specific drug might be available at reduced cost or for free.

Drug Assistance Programs: click HERE

At the Mesothelioma Research Foundation of America, you can call toll free (800) 909-Meso (6376) to talk with one of our Cancer Information Specialists who will gladly look up the phone numbers or the web site of the pharmaceutical company that makes the drug you are using


Find the lastest Mesothelioma clinical trials: click HERE

To ask your Cancer questions: click HERE

Help this Foundation and click HERE


Cancer imposes heavy economic burdens on a cancer patients and family members alike. Resources are available for individuals who do not have health insurance or who need financial assistance to cover health care costs. Our listing will help you find Government agencies, private organizations, and programs that are designed to provide assistance for a cancer patient and their family.

Financial help for cancer patients: click HERE

At the Mesothelioma Research Foundation of America, you can call toll free (800) 909-Meso (6376) to talk with one of our Cancer Information Specialists who will gladly look up the phone numbers or the web site of organizations that provide financial assistance.

Bring us your Mesothelioma cancer questions: click HERE

Help grow the Foundation and cancer-cure research: click HERE

Pause
Resume

THE FOUNDATION

The Mesothelioma Research Foundation of America has a mission: fund research that will lead to the quickest cure for mesothelioma. Mesothelioma is a cancer of the lining of the lungs caused by asbestos exposure. This cancer disease had few treatment options until this Foundation and Dr. Parkash Gill's work created better treatment options. Today, the future looks more hopeful for additional improved treatment options available to those stricken by this cancer.

James W. Kellogg, Jerry Neil Paul, Elizabeth Paul and Dr. Parkash Gill, M.D.
The Foundation Board Members from the left are: James W. Kellogg, Jerry Neil Paul, and Elizabeth Ann Paul. These are respectively the United Association International Representative, Founding Director, Executive Director and Dr. Parkash Gill, M.D. as Chairman of the Medical Advisory Committee.

The Mesothelioma Research Foundation of America began funding research for a cure in 2001 with the opening of the Mesothelioma Laboratory at USC Norris Comprehensive Cancer Medical Center in Los Angeles under the supervision of Dr. Parkash Gill.

Dr. Gill is a board certified oncologist and hematologist who has received FDA approval from the U.S. Government to do Clinical Trials on a mesothelioma treatment drug called Veglin. We believe there is great promise and hope in Veglin and the Mesothelioma Research Foundation of America has funded 100% of Dr. Gill's research.

Veglin proved successful in Phase I and Phase II clinical trials. Many are very hopeful for the possibilities of a more effective cancer treatment compared to what presently is available for mesothelioma victims. We are currently in FDA approved Clinical Trials with EPH-B4 which replaced the Veglin Trials.


2016 events

Posted: October 17, 2016

2016 District Council 16 Aim to Cure Mesothelioma Clayshoot

Once again, we returned to the Moore-N-Moore Sporting Clays facility in the San Fernando Valley, CA, which witnessed a great turnout, generating approximately $32,000 for mesothelioma research!

read more...

 
Posted: September 9, 2016

2016 Alta Vista Golf Invitational

On July 28th, the 2016 14th Annual District Council 16 Golf Invitational witnessed a huge turnout of over 140 golfers, who came together to support the cause while generating approximately $105k for mesothelioma research!

read more...

 

Posted: August 25, 2016

2016 AIM to CURE hosted by Jim Kellogg

The June 2016 “Aim to Cure” event hosted by Foundation Board Member and Retired International Pipetrades Representative Jim Kellogg saw another great turnout of over 100 supporters.

read more...

 
Posted: August 1, 2016

2016 Roger Hamilton Memorial Golf Invitational

We were overjoyed to hear from International Vice President of the Heat & Frost Insulators, Doug Gamble, and the Business Manager of Local 16 Heat & Frost Insulators, Mel Breshears, who decided to bring back the event that had become a staple of the Mesothelioma Research Foundation of America. 

read more...


Clinical Trials Status

Dr. Parkish Gill seeks  cure for mesothelioma cancer
Dr. Parkash Gill

 

Dr. Parkash Gill of the USC Norris Comprehensive Cancer Center has announced that the new cancer fighting drug EPH-B4 has been submitted to the FDA for Phase I Clinical Trials and is available to qualifying mesothelioma patients. In the initial Phase I Trial EPH-B4 is available to newly diagnosed patients who have not undergone any conventional treatment options and to those patients who have exhausted all other treatment options such as surgery and chemotherapy. This is truly exciting as Dr. Gill has reported that EPH-B4 has shown great promise as a solo treatment or in conjunction with other drugs as Alimta, Cisplatin and Carboplatin.


Please use our FaceBook link to obtain your FREE copy of our eBook that teaches:

10 Easy Steps On How To Find And Choose A Clinical Trial For Mesothelioma And How To Prepare For It!

Ask us questions about your specific mesothelioma issues here: Ask Questions

In addition to the eBook found at our Facebook fan page, also learn more about clinical trials from these links:


There have been significant improvements creating new options for patients with Mesothelioma lung cancer. This video presents the new options for a patient to be aware of and consider. This news release video, created by Med Page Today, is about Oncology and Lung Cancer has been shared on YouTube by the Mesothelioma Research Foundation of America.

 

 


Lyons Foundation Chooses MesoRFA

The Mesothelioma Research Foundation of America is the proud recipient of a grant from the John S. Lyons Memorial Foundation, charitable branch of the San Diego Building Trades Councel, to help support clinical studies of Dr. Parkash Gill's protein known as EPH B4 as a mesothelioma cancer treatment option.

John S. Lyons Memorial Foundation

Read More...

Top of Page